Pulmonary Fibrosis Clinical Trials

191 clinical trials for Pulmonary Fibrosis across international registries, including 34 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Retrospective Validation of AccuPulmo CT Portal for Detecting Pulmonary Fibrosis on Chest CT — RECRUITING
• Role of Genetic Factors in the Development of Lung Disease — RECRUITING
• Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis — RECRUITING · PHASE2
• Interstitial Lung Disease Research Unit Biobank — RECRUITING
• Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis — RECRUITING
• Implementation of Home Monitoring in Patients With Pulmonary Fibrosis — RECRUITING · NA
• P4O2 ILD Extension — RECRUITING
• Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects — RECRUITING · PHASE1
• Advanced Imaging for Pulmonary Fibrosis — RECRUITING · PHASE2
• A PHASE IIB STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF AZD8965 IN PARTICIPANTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) (ARGINAUT) — RECRUITING · PHASE2
• Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases — RECRUITING · PHASE1
• Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients — RECRUITING · PHASE1
• Telomeres Length in Israeli Fibrotic ILD Patients — RECRUITING
• Explanted Lung Tissues With Pulmonary Fibrosis — RECRUITING
• Routine vs On-demand ECMO for Lung Transplantation — RECRUITING · NA
• Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF) — RECRUITING
• A MULTINATIONAL, LONG-TERM, OPEN-LABEL EXTENSION STUDY OF SUBJECTS WHO HAVE PARTICIPATED IN AVALYN PHARMA STUDIES OF INHALED ANTIFIBROTIC AGENTS (AP-LTE-008 [SAIL]) — RECRUITING
• Physical Exercise Program for Adults With Diffuse Interstitial Lung Disease in a Pulmonary Rehabilitation Context — RECRUITING · NA
• FAPI PET for Lung Fibrosis — RECRUITING · PHASE1
• Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs — RECRUITING
• Pulmonary Fibrosis Foundation Community Registry — RECRUITING
• A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease — RECRUITING · NA
• A Non-pharmacological Cough Control Therapy — RECRUITING · NA
• Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath — RECRUITING
• Application of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis — RECRUITING · NA
• Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT — RECRUITING · PHASE1
• Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland — RECRUITING
• A PHASE 2, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL EVALUATING THE SAFETY AND EFFICACY OF ENV-101 IN PATIENTS WITH LUNG FIBROSIS (WHISTLE-PF TRIAL) — RECRUITING · PHASE2
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2B STUDY EVALUATING THE SAFETY AND EFFICACY OF PIRFENIDONE SOLUTION FOR INHALATION (AP01) IN SUBJECTS WITH PROGRESSIVE PULMONARY FIBROSIS (PPF) — RECRUITING · PHASE2
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTINATIONAL, PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF INHALED TREPROSTINIL IN SUBJECTS WITH PROGRESSIVE PULMONARY FIBROSIS (TETON-PPF) — RECRUITING · PHASE3
• Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases — RECRUITING · PHASE2
• AN OPEN-LABEL EXTENSION TRIAL OF THE LONG-TERM SAFETY AND EFFICACY OF BI 1015550 TAKEN ORALLY IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) AND PROGRESSIVE PULMONARY FIBROSIS (PPF) (FIBRONEER¿-ON) — RECRUITING
• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF BMS-986278 IN PARTICIPANTS WITH PROGRESSIVE PULMONARY FIBROSIS — RECRUITING · PHASE3
• European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank — RECRUITING
• Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis — NOT_YET_RECRUITING · PHASE3
• Analysis of Specimens From Individuals With Pulmonary Fibrosis — ACTIVE_NOT_RECRUITING
• Antifibrotic Therapy Decision-Making in Pulmonary Fibrosis — NOT_YET_RECRUITING
• A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis — ACTIVE_NOT_RECRUITING · PHASE2
• A RANDOMIZED, DOUBLE-BLIND, HEAD-TO-HEAD PHASE 3 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LYT-100 (DEUPIRFENIDONE) COMPARED TO PIRFENIDONE AT 52 WEEKS IN ADULTS WITH IDIOPATHIC PULMONARY FIBROSIS (SURPASS-IPF) — NOT_YET_RECRUITING · PHASE3
• Safety of Bronchoscopy in Patients With Interstitial Lung Disease — NOT_YET_RECRUITING
• NERANDOMILAST ADDED TO MYCOPHENOLATE FOR TREATMENT OF PULMONARY FIBROSIS (NERAM-PF): A SINGLE-ARM PROSPECTIVE STUDY — NOT_YET_RECRUITING
• This is a Trial Designed to Evaluate the Combination of Nerandomilast With Mycophenolate Across a Wide Variety of Pulmonary Fibrosis Subtypes, With the Aim of Providing Clinicians With Assurance That This is an Appropriate Therapeutic Combination. — NOT_YET_RECRUITING · PHASE4
• DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSIS — ACTIVE_NOT_RECRUITING
• The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 — COMPLETED · PHASE4
• Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment — COMPLETED · PHASE1
• AN OPEN-LABEL, MULTI-CENTER, LONG-TERM EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF ADMILPARANT IN PARTICIPANTS WITH PULMONARY FIBROSIS — NOT_YET_RECRUITING
• Dyspnea and Idiopathic Pulmonary Fibrosis — COMPLETED
• Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis — ACTIVE_NOT_RECRUITING
• Clinical Application of 68Ga-1A12 PET in Fibrosis-related Diseases — NOT_YET_RECRUITING
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers and the Effect of Itraconazole on CHF10073 Exposure — COMPLETED · PHASE1

Refine this search